Novartis Ag (NVSEF) Net Cash Flow (QoQ) (2009 - 2025)

Novartis Ag (NVSEF) Net Cash Flow (QoQ) (2009 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -144.65%
Sep 30, 2025 -8.59%
Jun 30, 2025 -340.00%
Mar 31, 2025 106.19%
Dec 31, 2024 -605.03%
Sep 30, 2024 50.65%
Jun 30, 2024 -70.41%
Mar 31, 2024 -105.70%
Dec 31, 2023 1,996.88%
Sep 30, 2023 27.65%
Jun 30, 2023 -584.52%
Mar 31, 2023 98.07%
Dec 31, 2021 -248.95%
Sep 30, 2021 -195.67%
Jun 30, 2021 64.84%
Mar 31, 2021 -83.55%
Dec 31, 2018 236.38%
Sep 30, 2018 -109.97%
Dec 31, 2017 -52.40%
Sep 30, 2017 -336.26%